Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02422550 · ClinicalTrials.gov registry record
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
A clinical trial of Radiation Therapy, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 837
- Enrollment target
- 7
- Study locations
NCT02422550 is a study of Radiation Therapy that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 837 participants, above the 50-participant average among 7 other Radiation Therapy trials with a reported enrollment target (1574% higher). The trial reports 7 study locations across 2 states.
The verdict
NCT02422550, a study of Radiation Therapy, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 837 participants
- Enrollment target
- 7
- Study locations
Study Summary
Magnetic resonance imaging (MRI) is currently one of the standard diagnostic imaging methods used to diagnose tumor stage before treatment in the Radiation Oncology Department. It is also used to check responses to radiation after treatment. However, MRI isn't traditionally used in planning for radiation treatment or in checking treated tumor and tissue changes during radiation treatment. The goal is to find out the possible benefits of MRI imaging techniques in these settings of radiation treatment. The research aims are to study the possibility of using devices with new abilities such as the MR-Linac. The MR-Linac combines a radiation treatment machine with a diagnostic MRI scanner. This device will improve the quality of MRI-guided radiation treatment. The MR-Linac has functions that are currently not available in other combined imaging and radiation delivery devices. The MR-Linac does not provide additional imaging capabilities that are not currently available in other imaging devices. Participating in this study would NOT change the current treatment plans, this will allow the investigators to use the MRI methods in research and future patient care.
Conditions Studied
Interventions
- DEVICE MRI or CT
Study Locations (7)
New York
- Memorial Sloan Kettering Commack (Consent Only) - Commack
- Memorial Sloan Kettering Westchester (Consent only) - Harrison
- Memorial Sloan Kettering Cancer Center - New York
- Memorial Sloan Kettering Nassau (Consent only) - Uniondale
New Jersey
- Memorial Sloan Kettering Basking Ridge (Consent only) - Basking Ridge
- Memorial Sloan Kettering Monmouth (Consent only) - Middletown
- Memorial Sloan Kettering Bergen (Consent only ) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 837 participants |
| Start Date | 2015-04-09 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02422550
The ClinicalTrials.gov registry entry for NCT02422550 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 837 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 50-participant average among 7 other Radiation Therapy trials with a reported enrollment target (1574% higher). The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Radiation Therapy appearing as the primary indexed condition, and to 1 intervention - of which MRI or CT is the first listed.
NCT02422550 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT02422550 about?
NCT02422550 is a clinical study titled "Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment". Magnetic resonance imaging (MRI) is currently one of the standard diagnostic imaging methods used to diagnose tumor stage before treatment in the Radiation Oncology Department. It is also used to check responses to radiation after treatment. However, MRI isn't traditionally used in planning for radi...
What is the current status of trial NCT02422550?
This trial is currently recruiting. The enrollment target is 837 participants. The study started on 2015-04-09. Estimated completion is 2027-04.
What conditions does trial NCT02422550 study?
This clinical trial studies the following conditions: Radiation Therapy.
What interventions are being tested in trial NCT02422550?
The interventions under investigation include: MRI or CT (DEVICE).
Who is sponsoring clinical trial NCT02422550?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02422550 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Therapy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
3D Specimen Maps for RT Planning
RECRUITING
-
Intraoral Hypothermia Device for Preserving Taste During Radiation
RECRUITING · Early Phase 1
-
Activity Coaching During Pelvic Radiation Therapy
RECRUITING · NA
-
18F-FLUC PET/MR in Patients With Brain Mets
RECRUITING · Phase 3
-
Improving Outcomes for Older Adults Undergoing Radiation Therapy
ACTIVE NOT RECRUITING
-
Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic Malignancies
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.